PTEN (gene)
of the PTEN protein (blue) complexed with tartaric acid (brown) PTEN (phosphatase and tensin homolog) is a gene found in humans which encodes for the protein PTEN, also known as phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase.
≈ 3 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
of the PTEN protein (blue) complexed with tartaric acid (brown) PTEN (phosphatase and tensin homolog) is a gene found in humans which encodes for the protein PTEN, also known as phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. PTEN acts as a tumor suppressor gene through the action of its phosphatase protein product.
Mutations of this gene are linked to many cancers, specifically glioblastoma, lung cancer, breast cancer, and prostate cancer. Genes corresponding to PTEN (orthologs) have been identified in most mammals for which complete genome data are available. The PTEN protein contains both a tensin-like domain and a catalytic domain similar to that of the dual specificity phosphatases.
Unlike most protein tyrosine phosphatases, the PTEN protein preferentially dephosphorylates phosphoinositide substrates. Specifically, it catalyzes the conversion of phosphatidylinositol-3,4,5-trisphosphate (PIP 3 ) to phosphatidylinositol 4,5-bisphosphate (PIP 2 ).
Decreased PIP 3 levels, in turn, lead to decreased activation of the Akt/PKB signaling pathway, an important pathway in cell growth, survival, and proliferation.
of the PTEN protein (blue) complexed with tartaric acid (brown) ]] PTEN (phosphatase and tensin homolog) is a gene found in humans which encodes for the protein PTEN, also known as phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. PTEN acts as a tumor suppressor gene through the action of its phosphatase protein product.
Mutations of this gene are linked to many cancers, specifically glioblastoma, lung cancer, breast cancer, and prostate cancer. Genes corresponding to PTEN (orthologs) have been identified in most mammals for which complete genome data are available. The PTEN protein contains both a tensin-like domain and a catalytic domain similar to that of the dual specificity phosphatases.
Unlike most protein tyrosine phosphatases, the PTEN protein preferentially dephosphorylates phosphoinositide substrates. Specifically, it catalyzes the conversion of phosphatidylinositol-3,4,5-trisphosphate (PIP 3 ) to phosphatidylinositol 4,5-bisphosphate (PIP 2 ).
Decreased PIP 3 levels, in turn, lead to decreased activation of the Akt/PKB signaling pathway, an important pathway in cell growth, survival, and proliferation.
PTEN inhibitors
Bisperoxovanadium compounds may have a neuroprotective effect after CNS injury. PTEN is inhibited by sarcopoterium. PTEN is one of the targets of the oncomiR, MIRN21.
Dance Your PhD 2017 : A Story of Tumor Suppression Deepti Mathur. PTEN and cancer explained in dance. A metabolic pathway uses glutamine to create a component of DNA.
This pathway is regulated in part by PTEN. Loss of PTEN allows the pathway to go into overdrive, leading to cancer. A drug that interrupts the PTEN pathway preferentially destroys cancer cells.
PDBe-KB provides an overview of all the structure information available in the PDB for Human Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN
Text derived from https://en.wikipedia.org/w/index.php?oldid=1376639301 under CC BY-SA 4.0; modifications have been made.